Europe Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology); Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Country

Code: TIPRE00014191 | Pages: 124 | Industry: Pharmaceuticals | Date: Sep 2020 | Type: Regional

Market Introduction

Liposomes are a novel drug delivery system (NDDS); are vesicular structures consisting of bilayers used to deliver drugs or genetic material into a cell. NDDS aims to provide the drug at a rate directed by the body's needs during the period of treatment. Thus, companies in the liposome drug delivery market capitalize on this opportunity to increase their research in nanomaterials such as nanospheres, liposomes, and active antiviral agents. Liposome drug delivery is being leveraged with increased in vivo and in vitro drug activities for routine clinical practices.


Get more information on this report :



Market Overview and Dynamics

The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast period. The growing R&D expenditure on drug delivery, growing demand for non-invasive drug delivery devices anddevelopment of new lipid composition for stability and optimization of drugs, are key drivers for liposome drug delivery market. However, the high cost for R&D and COVID-19 pandemic are likely to have a negative impact on market growth.

 

Key Market Segments

Based on the product, the liposomal doxorubicin segment held the highest share of the Europe liposome drug delivery market in 2019, whereas, liposomal amphotericin B segment is expected to grow at the fastest rate during the forecast period. Based on technology, stealth liposome technology segment held the largest share of the market and is anticipated to grow at the fastest rate during the forecast period. Based on application, cancer therapy segment held the largest share of the Europe liposome drug delivery market in 2019 and is expected to grow at the fastest rate during the forecast period.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources forEurope Liposome Drug Delivery Market included in the report are novel drug delivery system (NDDS), Celsion Corporation, European and Developing Countries Clinical Trials Partnership (EDCTP), EuropaBio, European Federation of Biotechnology (EFB).

 

 

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of the Europe Liposome Drug Delivery market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Liposome Drug Delivery segments in the top spending countries across the world and identify the opportunities offered by each of them.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the Europe Liposome Drug Delivery market, providing a clear picture of future opportunities that will be helpful to Analyse, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the Europe Liposome Drug Delivery market.

 

EUROPE LIPOSOME DRUG DELIVERY MARKET SEGMENTATION

Europe Liposome Drug Delivery Market – By Product

·         Liposomal Doxorubicin

·         Liposomal Paclitaxel

·         Liposomal Amphotericin B

·         Others

                                                                     

Europe Liposome Drug Delivery Market – By Technology

·         Stealth Liposome Technology

·         Non-PEGylated Liposome Technology

·         DepoFoam Liposome Technology

·         Lysolipid Thermally Sensitive Liposome (LTSL) Technology

 

Europe Liposome Drug Delivery Market – By Application

·         Fungal Diseases

·         Cancer Therapy

·         Pain Management

·         Viral Vaccines

·         Photodynamic Therapy

 

 

  Europe Liposome Drug Delivery Market – By Geography

  • UK
  • Germany
  • France
  • Italy
  • Spain

 

 

 

 

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Liposome Drug Delivery Market – By product type

1.3.2        Europe Liposome Drug Delivery Market – By Technology

1.3.3        Europe Liposome Drug Delivery Market – By Application

1.3.4        Europe Liposome Drug Delivery Market – By Country

2.           Liposome Drug Delivery Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Liposome Drug Delivery – Market Landscape

4.1         Overview

4.1.1        Europe– PEST Analysis

4.2         Expert Opinion

5.           Europe Liposome Drug Delivery Market – Industry Dynamics

5.1         Market Drivers

5.1.1        Rising prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        Increasing R&D Expenditures in Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Cost Involved in Development of Drug Delivery Systems

5.3         Market Opportunities

5.3.1        Development of New Lipid Composition for Stability and Optimization of Drugs

5.4         Future Trends

5.4.1        Increasing Popularity of Liposomes in Drug Delivery

5.5         Impact Analysis

6.           Liposome Drug Delivery Market –Asia Pacific Analysis

6.1         Europe Liposome Drug Delivery Market Revenue Forecast And Analysis

7.           Liposome Drug Delivery Market Analysis – By Product

7.1         Overview

7.2         Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

7.3         Liposomal Doxorubicin

7.3.1        Overview

7.3.2        Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Liposomal Paclitaxel

7.4.1        Overview

7.4.2        Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Liposomal Amphotericin B

7.5.1        Overview

7.5.2        Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.           Liposome Drug Delivery Market – By Technology

8.1         Overview

8.2         Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

8.3         Stealth Liposome Technology

8.3.1        Overview

8.3.2        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Non-PEGylated Liposome Technology

8.4.1        Overview

8.4.2        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5         DepoFoam Liposome Technology

8.5.1        Overview

8.5.2        Depo Foam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Lysolipid Thermally Sensitive Liposome (LTSL) Technology

8.6.1        Overview

8.6.2        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.           Liposome Drug Delivery Market – By Application

9.1         Overview

9.2         Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

9.3         Fungal Diseases

9.3.1        Overview

9.3.2        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Cancer Therapy

9.4.1        Overview

9.4.2        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Pain Management

9.5.1        Overview

9.5.2        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6         Viral Vaccine

9.6.1        Overview

9.6.2        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.7         Photodynamic Therapy

9.7.1        Overview

9.7.2        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.        Liposome Drug Delivery Market – Geographic Analysis

10.1      Europe: Liposome Drug Delivery Market

10.1.1     Overview

10.1.2     Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

10.1.3     Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5     Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.6     Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8     UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9     France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.10  Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.11  Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.        Impact Of COVID-19 Pandemic On European Liposome Drug Delivery Market

11.1      Europe: Impact assessment of COVID-19 Pandemic

12.        Liposome Drug Delivery Market –Company Profiles

12.1      Takeda Pharmaceutical Company Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Novartis AG

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Luye Pharma Group

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Johnson & Johnson Services, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Ipsen Pharma

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Gilead Sciences, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Celsion, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Astellas Pharma Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 15.          Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.          Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.          Glossary of Terms, Liposome Drug Delivery Market

LIST OF FIGURES

Figure 1.           Liposome drug delivery Market Segmentation

Figure 2.           Europe Liposome drug delivery Market

Figure 3.           The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market

Figure 4.           Europe PEST Analysis

Figure 5.           Europe Liposome Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027

Figure 6.           Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

Figure 7.           Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 8.           Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 9.           Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

Figure 12.        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Depo Foam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

Figure 16.        Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

Figure 17.        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Europe: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 25.        Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic In European Country Markets

 

  1. Takeda Pharmaceutical Company Limited
  2. Novartis AG
  3. Luye Pharma Group
  4. Johnson & Johnson Services, Inc
  5. Ipsen Pharma
  6. Gilead Sciences, Inc
  7. Celsion, Inc
  8. Astellas Pharma Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000